Financial results - CYTOPATH SRL

Financial Summary - Cytopath Srl
Unique identification code: 14547955
Registration number: J2002000141093
Nace: 8691
Sales - Ron
160.141
Net Profit - Ron
4.411
Employees
4
Open Account
Company Cytopath Srl with Fiscal Code 14547955 recorded a turnover of 2024 of 160.141, with a net profit of 4.411 and having an average number of employees of 4. The company operates in the field of Servicii de diagnostic imagistic și activități ale laboratoarelor medicale having the NACE code 8691.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Cytopath Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 99.712 91.917 121.149 134.188 137.143 112.116 141.146 175.840 176.204 160.141
Total Income - EUR 99.742 93.960 121.172 134.198 137.657 172.917 141.146 191.049 178.943 160.141
Total Expenses - EUR 89.243 88.116 107.411 108.929 105.274 135.183 101.555 128.175 148.205 152.092
Gross Profit/Loss - EUR 10.499 5.844 13.762 25.269 32.383 37.733 39.591 62.874 30.738 8.049
Net Profit/Loss - EUR 7.238 4.909 4.677 23.927 31.007 36.721 38.349 61.002 29.249 4.411
Employees 5 4 3 4 3 3 4 4 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -8.6%, from 176.204 euro in the year 2023, to 160.141 euro in 2024. The Net Profit decreased by -24.674 euro, from 29.249 euro in 2023, to 4.411 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Cytopath Srl

Rating financiar

Financial Rating -
CYTOPATH SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Cytopath Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cytopath Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Cytopath Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cytopath Srl - CUI 14547955

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 95.122 121.611 113.778 99.930 88.261 41.438 37.328 97.603 82.521 72.077
Current Assets 78.666 77.083 91.483 115.381 140.433 139.991 172.248 115.323 105.544 100.728
Inventories 846 18.665 824 2.709 176 55 0 1.237 0 0
Receivables 52.214 52.653 53.390 44.449 44.168 24.074 23.077 70.497 108.661 101.977
Cash 25.606 5.765 37.270 68.223 96.090 115.862 149.171 43.590 -3.117 -1.249
Shareholders Funds 76.725 65.265 68.837 91.501 120.736 145.811 180.926 111.209 84.250 71.771
Social Capital 112 111 109 107 105 103 101 101 101 101
Debts 97.127 133.430 136.423 123.809 108.108 35.850 29.097 102.085 104.075 101.523
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8691 - 8691"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 100.728 euro in 2024 which includes Inventories of 0 euro, Receivables of 101.977 euro and cash availability of -1.249 euro.
The company's Equity was valued at 71.771 euro, while total Liabilities amounted to 101.523 euro. Equity decreased by -12.008 euro, from 84.250 euro in 2023, to 71.771 in 2024.

Risk Reports Prices

Reviews - Cytopath Srl

Comments - Cytopath Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.